# US 8,277,868 B2 · Balloon catheter for delivering therapeutic agents

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,868 B2
- Document ID: US8277868B2
- Status: Granted
- Kind: B2
- Application number: 12/642,612
- Filed: 2009-12-18
- Published: 2010-07-29
- Granted: 2012-10-02
- Earliest claimed: 2001-01-05
- Assignees: Abbott Cardiovascular Systems Inc.
- Inventors: Lyudmila Kokish; Stephen D. Pacetti; John Stankus
- Web page: https://patentgrep.com/patent/US8277868B2

## CPC

- A61L 29/085: {Macromolecular materials}
- A61L 29/146: {Porous materials, e.g. foams or sponges}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61M 25/10: Balloon catheters ({A61M25/0125 takes precedence; embolectomy A61B17/22032; retractors A61B17/02;} inflatable balloons for placing stents or stent-grafts A61F2/958 {; stomach balloons for treatment of obesity A61F5/0003; oesophagal tubes A61J15/00})
- A61M 25/1027: {Making of balloon catheters}
- A61L 2300/606: Coatings
- A61L 2420/02: Methods for coating medical devices
- A61M 2025/105: {having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes}
- A61M 2025/1075: {having a balloon composed of several layers, e.g. by coating or embedding}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A drug delivery device for delivering therapeutic agents and a method of making such a device is disclosed. The device includes an inflatable balloon. A microporous coating covers a portion of the outer surface of the wall of the balloon. The thickness of the coating and the size of the micropores can permit desirable delivery of a substance from the micropores of the coating and into the tissue of a patient's lumen.

## Claims

### Claim 1

A method of coating a drug delivery device, comprising:
applying a composition onto an outer surface of an inflatable balloon integrated with a catheter, the composition including a polymer mixed with a first fluid and optionally a drug;
applying a second fluid to the composition on the outer surface of the balloon, wherein the second fluid is a poorer solvent for the polymer than the first fluid, and wherein the second fluid evaporates less rapidly than the first fluid; and
removing the first and second fluids to form a porous precipitate coating, wherein the inner surface of the porous precipitate coating is in intimate contact with a majority of the outer surface of the balloon.

### Claim 2 (depends on 1)

The method of claim 1, wherein the drug is used and the second fluid is a poorer solvent for the drug than the first fluid.

### Claim 3 (depends on 1)

The method of claim 1, wherein the size of the pores is in a range from approximately 0.001 mm to 0.020 mm.

### Claim 4 (depends on 1)

The method of claim 1, wherein a thickness of the porous precipitate coating is in a range from approximately 0.005 mm to 0.040 mm.

### Claim 5 (depends on 1)

The method of claim 1, wherein the polymer is selected from the group consisting of poly(vinyl pyrrolidone), poly(ethylene glycol), pluronics, silk-elastin like protein polymers, carboxymethylcellulose, silicones, polyesters and polyurethanes.

### Claim 6 (depends on 1)

The method of claim 1, wherein the first fluid is selected from the group consisting of acetone, methanol, ethanol, isopropanol, tetrahydrofuran, dimethylacetamide, dimethylformamide, dimethylsulfoxide and dioxane.

### Claim 7 (depends on 1)

The method of claim 1, wherein the drug is used and is selected from the group consisting of antithrombotics, antiproliferatives, anti-inflammatory agents, smooth muscle cell migration inhibitors, reendothelialization agents and restenosis-reducing drugs.

### Claim 8

A method for making a drug delivery device, comprising:
applying a composition onto an outer surface of an inflatable balloon, the inflatable balloon secured at a distal end of a catheter-based device, and the composition including a polymer, a first fluid, a second fluid, and a drug, wherein the second fluid is a poorer solvent for the polymer than the first fluid, and wherein the second fluid evaporates less rapidly than the first fluid; and
drying the composition to produce a microporous coating on the inflatable balloon, wherein the inner surface of the microporous coating is in intimate contact with a majority or all of the outer surface of the balloon.

### Claim 9 (depends on 8)

The method of claim 8, further comprising partially inflating the inflatable balloon with an inflation fluid prior to or during application of the composition.

### Claim 10 (depends on 9)

The method of claim 9, wherein the inflating is performed at a variable pressure within the range of approximately 1 psi to 2 psi.

### Claim 11 (depends on 8)

The method of claim 8, wherein the act of applying includes simultaneously spraying the first fluid and the second fluid onto the inflatable balloon.

### Claim 12 (depends on 8)

The method of claim 8, wherein the size of the pores is in a range from approximately 0.001 mm to 0.020 mm.

### Claim 13 (depends on 8)

The method of claim 8, wherein a thickness of the microporous coating is in a range from approximately 0.005 mm to 0.040 mm and the dosage of the drug is about 300 μg/cm2 to 600 μg/cm2.

### Claim 14 (depends on 8)

A method of claim 8, wherein the inner surface of the microporous coating is in intimate contact with the majority or all of the outer surface of the balloon so as not to include a gap between the microporous coating and the balloon.

### Claim 15 (depends on 1)

The method of claim 1, further comprising:
inflating, at least partially, the inflatable balloon with an inflation fluid.

### Claim 16 (depends on 1)

The method of claim 1, wherein one or more additional porous precipitate coatings are formed upon the porous precipitate coating.

### Claim 17 (depends on 16)

The method of claim 16, wherein the one or more additional porous precipitate coatings are formed using additional compositions that are the same as the composition.

### Claim 18 (depends on 16)

The method of claim 16, wherein at least one of the one or more additional porous precipitate coatings is formed using an additional composition that is different from the composition.
